About Enancio
Enancio is a Healthcare company based in Cesson-sevigne (France) founded in 2015 by Guillaume Rizk and Yvan Le Bras, and was acquired by Illumina in July 2020. Next-generation sequencing analysis and genomic data compression are provided. Its chief executive, as recorded, is Jennifer Del Giudice. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.
Company details
Enancio was founded in 2015 and is based in Cesson Sevigne, France. Operations focus on the biotechnology sector, where next-generation sequencing analysis is delivered through proprietary software called Lena. This software handles biological data, with specialization in the compression of fastq files and genomic datasets. Services support research and analysis needs in genomics.
- Headquarters Cesson-sevigne, France
- Founders Guillaume Rizk, Yvan Le Bras
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website enancio.com
- Social LinkedIn
- Acquired by Illumina (Jul 2020)
Investors in Enancio
Enancio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Illumina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Enancio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enancio
3 people are tracked at Enancio (3 in leadership).
| Name | Role | Group |
|---|---|---|
Guillaume Rizk | Co-Founder & CTO | Leadership |
Yvan Le Bras | Co-Founder | Leadership |
Jennifer Del Giudice | CEO | Leadership |
Complete people profiles for Enancio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enancio
2 dated milestones of Enancio across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Enancio is founded.
- Exit Acquired by Illumina.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Enancio
Complete news archive for Enancio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enancio
Enancio was founded in 2015.
Enancio is headquartered in Cesson-sevigne, France. It is registered at Cesson-sevigne, Ille-et-vilaine, France.
Jennifer Del Giudice is the CEO of Enancio, as recorded in our data.
Enancio was founded in 2015 and is based in Cesson Sevigne, France. Operations focus on the biotechnology sector, where next-generation sequencing analysis is delivered through proprietary software called Lena. This software handles biological data, with specialization in the compression of fastq files and genomic datasets. Services support research and analysis needs in genomics.
Enancio has 1 investor. Key investors include Illumina.
Yes. Enancio was acquired by Illumina in July 2020.